Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Juho Jalkanen Insider Profile
4 Followers
Juho Jalkanen, Interim Chief Medical Officer at Faron Pharmaceuticals Oy, holds 1.09M shares in Faron Pharmaceuticals Oy (Ticker: GB:FARN). Most recently, Juho Jalkanen Bought 12,000p shares of Faron Pharmaceuticals Oy on Jun 22, 2018 for an estimated value of 8.52K.
Juho Jalkanen has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Interim Chief Medical Officer
Roles that Juho Jalkanen holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Juho Jalkanen
Juho Jalkanen's Trading History
List of latest transactions for each holding click on a transaction to see Juho Jalkanen's performance on stock
You May Also Like
Juho Jalkanen insider profile FAQ
What is the percentage of profitable transactions made by Juho Jalkanen?
The percentage of profitable transactions made by Juho Jalkanen is ―.
What is the average return per transaction made by Juho Jalkanen?
The average return per transaction made by Juho Jalkanen is ―.
What stocks does Juho Jalkanen hold?
Juho Jalkanen holds: GB:FARN stocks.
What was Juho Jalkanen’s latest transaction?
Juho Jalkanen latest transaction was an Informative Buy of 8.52K.
What was Juho Jalkanen's most profitable transaction?
Juho Jalkanen’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Juho Jalkanen's role in Faron Pharmaceuticals Oy?
Juho Jalkanen's role in Faron Pharmaceuticals Oy is Interim Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.